Aggressive locoregional management of recurrent peritoneal sarcomatosis-Reference-Cited by-同舟云学术

Aggressive locoregional management of recurrent peritoneal sarcomatosis

Published:2013-02-05 Issue:4 Volume:107 Page:329-334
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Baumgartner Joel M.,Ahrendt Steven A.,Pingpank James F.,Holtzman Matthew P.,Ramalingam Lekshmi,Jones Heather L.,Zureikat Amer H.,Zeh Herbert J.,Bartlett David L.,Choudry Haroon A.

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference26 articles.

1. Retroperitoneal sarcomas: Grade and survival;Ferrario;Arch Surg,2003

2. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging;Ng;Ann Surg,1992

3. Tumor volume as a prognostic factor for sarcomatosis;Bilimoria;Cancer,2002

4. Multifocality in retroperitoneal sarcoma: A prognostic factor critical to surgical decision-making;Anaya;Ann Surg,2009

5. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer;Verwaal;J Clin Oncol,2003

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ibero-American Consensus for the Management of Peritoneal Sarcomatosis: Updated Review and Clinical Recommendations;Cancers;2024-07-25

2. Radical resection and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of high risk recurrent retroperitoneal sarcoma—A pilot study in a tertiary Asian centre;PLOS ONE;2024-04-04

3. Cytoreductive Surgery with Bidirectional Intraoperative Chemotherapy (BDIC) Using Intravenous Ifosfamide Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Peritoneal Sarcomatosis: A Retrospective Cohort Study;Annals of Surgical Oncology;2024-01-03

4. Malignant adipocytic tumours: A 20‑year single‑centre retrospective study;Oncology Letters;2023-04-21

5. Management of recurrent retroperitoneal sarcomas;European Journal of Surgical Oncology;2022-06